Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Institut Claudius Regaud
Centre Antoine Lacassagne
Roswell Park Cancer Institute
Thomas Jefferson University
University of Pittsburgh
University of California, San Francisco
Instituto Nacional de Cancer, Brazil
Hoosier Cancer Research Network
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Assistance Publique - Hôpitaux de Paris
St. Jude Children's Research Hospital
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
NGM Biopharmaceuticals, Inc
Eastern Cooperative Oncology Group
AstraZeneca
National Institutes of Health Clinical Center (CC)
CG Oncology, Inc.
Dana-Farber Cancer Institute
University of Utah
Assistance Publique - Hôpitaux de Paris
ClearNote Health
InxMed (Shanghai) Co., Ltd.
Methodist Health System
Methodist Health System
Canisius-Wilhelmina Hospital
Gustave Roussy, Cancer Campus, Grand Paris
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Guangzhou Bio-gene Technology Co., Ltd
National Institutes of Health Clinical Center (CC)
University of California, San Francisco
Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc.
Medical College of Wisconsin
The Royal Wolverhampton Hospitals NHS Trust
Assistance Publique - Hôpitaux de Paris
Rush University Medical Center
M.D. Anderson Cancer Center
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Universidad Europea de Canarias
Universidad Europea de Canarias
University of Hull
University Health Network, Toronto
University of Alabama at Birmingham
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Timser SAPI de CV
Cofactor Genomics, Inc.
Montefiore Medical Center